Details for New Drug Application (NDA): 091117
✉ Email this page to a colleague
NDA 091117 describes CEFTRIAXONE SODIUM, which is a drug marketed by Anda Repository and Hikma and is included in two NDAs. It is available from one supplier. Additional details are available on the CEFTRIAXONE SODIUM profile page.
The generic ingredient in CEFTRIAXONE SODIUM is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
The generic ingredient in CEFTRIAXONE SODIUM is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.
Summary for 091117
| Tradename: | CEFTRIAXONE SODIUM |
| Applicant: | Anda Repository |
| Ingredient: | ceftriaxone sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 091117
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 10GM BASE/VIAL | ||||
| Approval Date: | Jan 20, 2017 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
